BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37573945)

  • 21. A systematic evaluation of population pharmacokinetic models for polymyxin B in patients with liver and/or kidney dysfunction.
    Li X; Cheng Y; Zhang B; Chen B; Chen Y; Huang Y; Lin H; Zhou L; Zhang H; Liu M; Que W; Qiu H
    J Pharmacokinet Pharmacodyn; 2024 Apr; ():. PubMed ID: 38625507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
    Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
    Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Schatz LM; Brinkmann A; Röhr A; Frey O; Greppmair S; Weinelt F; Zoller M; Scharf C; Hempel G; Liebchen U
    Antimicrob Agents Chemother; 2023 May; 67(5):e0010423. PubMed ID: 37125925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.
    Greppmair S; Brinkmann A; Roehr A; Frey O; Hagel S; Dorn C; Marsot A; El-Haffaf I; Zoller M; Saller T; Zander J; Schatz LM; Scharf C; Briegel J; Minichmayr IK; Wicha SG; Liebchen U
    Intensive Care Med; 2023 Aug; 49(8):966-976. PubMed ID: 37439872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External Evaluation of Population Pharmacokinetics and Pharmacodynamics in Linezolid-Induced Thrombocytopenia: The Transferability of Published Models to Different Hospitalized Patients.
    Ogami C; Tsuji Y; Nishi Y; Kawasuji H; To H; Yamamoto Y
    Ther Drug Monit; 2021 Apr; 43(2):271-278. PubMed ID: 33009290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating nonlinear kinetics to improve predictive performance of population pharmacokinetic models for ciclosporin in adult renal transplant recipients: A comparison of modelling strategies.
    Mao J; Jiao Z; Qiu X; Zhang M; Zhong M
    Eur J Pharm Sci; 2020 Oct; 153():105471. PubMed ID: 32682934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models.
    Dhaese SAM; Farkas A; Colin P; Lipman J; Stove V; Verstraete AG; Roberts JA; De Waele JJ
    J Antimicrob Chemother; 2019 Feb; 74(2):432-441. PubMed ID: 30376103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease.
    Santacana E; Rodríguez-Alonso L; Padullés A; Guardiola J; Rodríguez-Moranta F; Serra K; Bas J; Morandeira Biology F; Colom H; Padullés N
    Ther Drug Monit; 2018 Feb; 40(1):120-129. PubMed ID: 29200097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients.
    Yang N; Wang J; Xie Y; Ding J; Wu C; Liu J; Pei Q
    Front Pharmacol; 2022; 13():838205. PubMed ID: 35662716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.
    Deng C; Liu T; Wu K; Wang S; Li L; Lu H; Zhou T; Cheng D; Zhong X; Lu W
    J Clin Pharm Ther; 2013 Dec; 38(6):480-9. PubMed ID: 24033587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Performance of Published Tacrolimus Population Pharmacokinetic Models in Thai Kidney Transplant Patients.
    Methaneethorn J; Lohitnavy M; Onlamai K; Leelakanok N
    Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):105-116. PubMed ID: 34817826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and Application of Population Pharmacokinetic Models for Identifying Delayed Methotrexate Elimination in Patients With Primary Central Nervous System Lymphoma.
    Mao J; Li Q; Li P; Qin W; Chen B; Zhong M
    Front Pharmacol; 2022; 13():817673. PubMed ID: 35355729
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients.
    Hanafin PO; Nation RL; Scheetz MH; Zavascki AP; Sandri AM; Kwa AL; Cherng BPZ; Kubin CJ; Yin MT; Wang J; Li J; Kaye KS; Rao GG
    CPT Pharmacometrics Syst Pharmacol; 2021 Dec; 10(12):1525-1537. PubMed ID: 34811968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population Pharmacokinetics and Dosage Optimization of Linezolid in Critically Ill Pediatric Patients.
    Yang M; Zhao L; Wang X; Sun C; Gao H; Wang X; Qian S
    Antimicrob Agents Chemother; 2023 May; 95(5):. PubMed ID: 33558298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards Precision Dosing of Clozapine in Schizophrenia: External Evaluation of Population Pharmacokinetic Models and Bayesian Forecasting.
    Lereclus A; Korchia T; Riff C; Dayan F; Blin O; Benito S; Guilhaumou R
    Ther Drug Monit; 2022 Oct; 44(5):674-682. PubMed ID: 35385439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Published population pharmacokinetic models of valproic acid in adult patients: a systematic review and external validation in a Chinese sample of inpatients with bipolar disorder.
    Zang YN; Guo W; Dong F; Li AN; de Leon J; Ruan CJ
    Expert Rev Clin Pharmacol; 2022 May; 15(5):621-635. PubMed ID: 35536685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice.
    Decrocq-Rudler MA; Chan Kwong AHP; Meunier L; Fraisse J; Ursic-Bedoya J; Khier S
    Ther Drug Monit; 2021 Aug; 43(4):490-498. PubMed ID: 33560099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients.
    Kirubakaran R; Hennig S; Maslen B; Day RO; Carland JE; Stocker SL
    Br J Clin Pharmacol; 2022 Feb; 88(4):1751-1772. PubMed ID: 34558092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External validation of population pharmacokinetic models of tacrolimus in Thai adult liver transplant recipients.
    Komenkul V; Sukarnjanaset W; Komolmit P; Wattanavijitkul T
    Eur J Clin Pharmacol; 2024 May; ():. PubMed ID: 38695888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.